Study of the potential radioprotective effects of probiotic bacteria to mitigate gastrointestinal complications after conventional radiotherapy

Phase 3

Recruiting

• Conditions: Condition 1: Colorectal Cancer. Condition 2: Colorectal Cancer.; Malignant neoplasm of colon; Malignant neoplasm of rectum

• Registration Number: IRCT20210704051788N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Adults with colorectal cancer who are candidates for radiotherapy as part of their treatment

Exclusion Criteria

Consumption of narcotic painkillers
Existence of acute and chronic gastrointestinal complications before starting treatment
Take any antibiotics one week before the start to end of radiotherapy
Received radiation therapy in the abdomen and pelvis in recent years
Use probiotic supplements during the 15 days before the study and also take other probiotic forms including probiotic yogurt and other fermented foods

Study & Design

• Study Type: interventional
• Study Design: Not specified